DAA509 |
BCL2-associated athanogene 2 |
Molecular |
skeletal muscle |
Human |
BAG2 |
3.0% Decrease Gene Expression Level |
|
DAA354 |
BCS1-like (yeast) |
Molecular |
skeletal muscle |
Human |
BCS1L |
3.0% Decrease Gene Expression Level |
|
DAA477 |
bolA homolog 3 (E. coli) |
Molecular |
skeletal muscle |
Human |
BOLA3 |
5.0% Decrease Gene Expression Level |
|
DAA653 |
Bone becomes more brittle, less flexible |
Physiological |
bone |
Human |
— |
— |
|
DAA650 |
Bone density of total hip and femoral neck decreases |
Physiological |
bone |
Human |
— |
— |
|
DAA648 |
Bone mass decreases |
Physiological |
bone |
Human |
— |
— |
|
DAA649 |
Bone mineral density in cortical ulna decreases |
Physiological |
ulna |
Human |
— |
— |
|
DAA568 |
bone morphogenetic protein receptor, type IB |
Molecular |
skeletal muscle |
Human |
BMPR1B |
11.0% Decrease Gene Expression Level |
|
DAA651 |
Bone porosity increases |
Physiological |
bone |
Human |
— |
— |
|
DAA645 |
Bone remodeling decreases |
Physiological |
bone |
Human |
— |
— |
|
DAA647 |
Bone resorption increases for cortical bone |
Physiological |
bone |
Human |
— |
— |
|
DAA541 |
brain protein 44-like |
Molecular |
skeletal muscle |
Human |
BRP44L |
5.0% Decrease Gene Expression Level |
|
DAA453 |
butyrophilin-like 3 |
Molecular |
skeletal muscle |
Human |
BTNL3 |
5.0% Decrease Gene Expression Level |
|
DAA419 |
cadherin 5, type 2 (vascular endothelium) |
Molecular |
skeletal muscle |
Human |
CDH5 |
6.0% Decrease Gene Expression Level |
|
DAA665 |
Calcification makes cartilage more brittle |
Physiological |
cartilage |
Human |
— |
— |
|
DAA663 |
Calcification of cartilage matrix |
Physiological |
cartilage |
Human |
— |
— |
|
DAA801 |
Calcification of costal cartilage |
Physiological |
thorax, cartilage |
Human |
— |
— |
|
DAA443 |
carbonic anhydrase IV |
Molecular |
skeletal muscle |
Human |
CA4 |
6.0% Decrease Gene Expression Level |
|
DAA666 |
Cartilage asbestos transformation |
Physiological |
cartilage |
Human |
— |
— |
|
DAA664 |
Cartilage calcification interferes with normal diffusion metabolism |
Physiological |
cartilage |
Human |
— |
— |
|
DAA658 |
Cartilage color changes |
Physiological |
cartilage |
Human |
— |
— |
|
DAA660 |
Cartilage joint surface cracks and frays |
Physiological |
cartilage |
Human |
— |
— |
|
DAA667 |
Cartilage matrix softening and cavity formation |
Physiological |
cartilage |
Human |
— |
— |
|
DAA661 |
Cartilage matrix synthesis to degradation ratio decreases |
Physiological |
cartilage |
Human |
— |
— |
|
DAA318 |
5'-3' exoribonuclease 1 |
Molecular |
skeletal muscle |
Human |
ERI1 |
4.0% Increase Gene Expression Level |
|